Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study

The only potential cure for patients with myelodysplastic syndrome (MDS) is allogeneic hematopoietic stem cell transplantation (HCT). However, a proportion of patients who are HCT candidates do not finally get transplanted. This population-based study aimed to characterize HCT candidates were attemp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindholm, C., Olofsson, E., Creignou, M., Nilsson, L., Garelius, H. Gravdahl, Cammenga, J., Ljungman, P., Ejerblad, E., Tobiasson, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993688/
https://www.ncbi.nlm.nih.gov/pubmed/35105966
http://dx.doi.org/10.1038/s41409-022-01582-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993688/
https://www.ncbi.nlm.nih.gov/pubmed/35105966
http://dx.doi.org/10.1038/s41409-022-01582-0

Ejemplares similares